Satva Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 335.42%
- Profit Growth 41.18%
- Ebitda 41.34%
- Net Worth -22.83%
- Total Assets 150.39%
About Satva Biotech
Satva Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 October 2015 (Nine years and four months 20 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bijal Thakker and Pradeep Shethia serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999MH2015PTC269013
- Company No.
269013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Satva Biotech Private Limited offer?
Satva Biotech Private Limited offers a wide range of products and services, including Protein Supplements, Whey Protein, Workout Essential.
Who are the key members and board of directors at Satva Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bijal Thakker  | Director | 08-Oct-2015 | Current |
| Pradeep Shethia | Director | 08-Oct-2015 | Current |
Financial Performance of Satva Biotech.
Satva Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 335.42% increase. The company also saw a substantial improvement in profitability, with a 41.18% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Satva Biotech?
In 2023, Satva Biotech had a public holding of 49.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Madhusudan Brothers LimitedPradeep Shethia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Satva Biotech?
Unlock and access historical data on people associated with Satva Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satva Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satva Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.